Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Description

The CLEAN (ChLorine to reduce Enteric and Antibiotic resistant infections in Neonates) cluster randomized controlled trial in western Kenya will evaluate the impact of a multi-component chlorination intervention in health care facilities on maternal and neonatal health. Intervention facilities will receive a passive chlorination technology for water supply treatment and a reliable supply of sodium hypochlorite disinfectant. Both intervention and treatment facilities will receive infection prevention and control messaging. The goal of the study is to evaluate the impact of the intervention on bacterial contamination of water supply, on staff hands, and on high-touch surfaces in maternity wards, and the following outcomes among facility-born neonates and their mothers: (1) gut carriage of bacterial pathogens associated with sepsis one week post-birth, (2) gut carriage of antibiotic resistant bacteria one week post-birth, and (3) symptoms of possible serious bacterial infection one week following birth.

Conditions

Sepsis, Neonatal Mortality, Antibiotic Resistant Infection, Enteric Infections, Serious Bacterial Infection

Study Overview

Study Details

Study overview

The CLEAN (ChLorine to reduce Enteric and Antibiotic resistant infections in Neonates) cluster randomized controlled trial in western Kenya will evaluate the impact of a multi-component chlorination intervention in health care facilities on maternal and neonatal health. Intervention facilities will receive a passive chlorination technology for water supply treatment and a reliable supply of sodium hypochlorite disinfectant. Both intervention and treatment facilities will receive infection prevention and control messaging. The goal of the study is to evaluate the impact of the intervention on bacterial contamination of water supply, on staff hands, and on high-touch surfaces in maternity wards, and the following outcomes among facility-born neonates and their mothers: (1) gut carriage of bacterial pathogens associated with sepsis one week post-birth, (2) gut carriage of antibiotic resistant bacteria one week post-birth, and (3) symptoms of possible serious bacterial infection one week following birth.

Multi-component Chlorination Intervention to Reduce Neonatal Infections in Rural Health Facilities

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Condition
Sepsis
Intervention / Treatment

-

Contacts and Locations

Berkeley

University of California, Berkeley, Berkeley, California, United States, 94720

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Public health care facility
  • * 25 live births or more per month
  • * Infrastructure compatible with inline chlorination device
  • * Existing facility-level chlorination

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, Berkeley,

Amy J Pickering, PhD, PRINCIPAL_INVESTIGATOR, University of California, Berkeley

Phelgona Otieno, PhD, PRINCIPAL_INVESTIGATOR, Kenya Medical Research Institute

Lillian Musila, PhD, PRINCIPAL_INVESTIGATOR, Walter Reed Army Institute of Research-Africa

Study Record Dates

2027-07